Research Article
Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities
Table 2
Percentage use NPS.
| | Types of novel psychoactive substances | Percentage use (%) | | Healthy subjects | Patients |
| “Spices”
Synthetic cannabinoids | 1% | 5.8% | “Bath salts”
Mephedrone | 0.3% | 0.5% | “Ice-shaboo-crystal meth”
Methamphetamine | 1.6% | 3.4% | | Ayahuasca | 0.2% | 0.5% | “Nbome-fly-solaris”
Phenethylamines | 0.6% | 0.5% | | Salvia divinorum | 1.1% | 1% | | Kratom | 0.1% | 0% | “Ghb”
Gamma hydroxybutyric acid | 0.3% | 1.9% | “Special m”
Methoxetamine | 0.2% | 1% | “Krokodil”
Desomorphine | 0.2% | 0% |
|
|
